OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor
OS Therapies has appointed Dr. Craig Eagle as Chief Medical Advisor, strengthening the company's medical, regulatory, and commercial leadership. The appointment is in preparation for potential early market access decisions from regulators in the U.S., U.K., Europe, and Australia for OST-HER2, expected by year-end 2026. Dr.
Key figures
- Designations received
- ["ODD","FTD","RPDD","ATMP"]
- Regulatory meetings upcoming
- FDA and MHRA
- Regulatory meetings completed
- EMA and ATGA
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.